Are peptides proven to work?

This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

Is every peptide a sure thing?

If you have spent five minutes on the internet lately, you probably think peptides are the answer to everything from weight loss to eternal youth. It would be great if every single one was a proven success, but science is rarely that cooperative.

In reality, peptides are all over the map. Some have mountains of evidence, some are stuck in the middle, and others are still just a big "maybe."

The gold standards

When we talk about things that are actually proven, we look for an FDA-Approved status. These are the peptides that have been through the ringer and came out with high grades like an A+.

• Semaglutide: This is a GLP-1 receptor agonist that mimics a hormone in your body. It has been shown to result in 14.9% weight loss in major trials like STEP 1.
• Tirzepatide: This one is a dual agonist, meaning it hits two different receptors. It actually outperformed semaglutide in head-to-head tests and showed 22.5% weight loss in its own major study.
• Tesamorelin: This Grade A peptide is FDA-approved, but specifically for HIV-associated lipodystrophy. It can reduce visceral fat (the deep belly fat) by 18%, but those effects completely reverse if you stop using it.

The "it depends" category

Then there are peptides that work for specific things but have some confusing baggage. Take MK-677 (which isn't even a peptide in the strict sense, but a small-molecule ghrelin mimetic). While it showed a 1.1kg gain in fat-free mass in a two-year study, it also raised fasting glucose and failed to help in Alzheimer’s trials. Scientists are still working on this one — turns out the human body is complicated.

Then you have Thymosin Alpha-1. It has been used in over 1,000 patients in hepatitis trials and is approved in 35+ countries, yet it is NOT FDA-approved in the US. Even with all that data, its results in cancer treatment have been disappointing, and no one knows the best dose for anti-aging.

The "too new to tell" group

Finally, there are the ones that look amazing on paper but aren't quite ready for the main stage. Retatrutide is a triple agonist that showed a massive 24.2% weight loss in Phase II trials. However, the Phase III results are still pending. We only have data from about 338 people so far, and it seems to have a higher rate of side effects than its cousins.

It is not all sunshine and roses

Even the "proven" ones have issues you should know about. For example, semaglutide has over 180,000 reports of side effects, including:

• Strong signals for nausea (affecting 44% of people) and vomiting.
• Delayed gastric emptying, which means your stomach slows down how fast it moves food.
• Emerging signals for more serious stuff like intestinal obstructions.

Plus, for almost all of these, weight regain is substantial if you stop. This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.